The range of specificity of the CFU-S proliferation inhibitor and stimulator which are produced endogenously in the bone marrow has been investigated by measuring their effects on the proportion of cells killed by tritiated thymidine in mixed colony-(CFC-mix), erythroid burst-(BFU-E) and granulocyte/ macrophage colony-(GM-CFC) forming cells as well as spleen colony forming units (CFU-S). Both CFU-S and CFC-mix were triggered by the stimulator into DNA-synthesis but BFU-E and GM-CFC were unaffected. The range of activity of the inhibitor was confined solely to the CFU-S population. This defined the specificity of both inhibitor and stimulator for the multipotent cells. The differential sensitivity of CFU-S and CFC-mix to the inhibitor and the lack of it for the stimulator suggested (a) that the CFC-mix is a relatively mature subpopulation of the CFU-S compartment and (b) that the relative sensitivity of a CFU-S to these factors changes as it matures from the early stem cell stage (Inhibitor-sensitive) to the more mature stages (Stimulator-sensitive) before becoming committed to a specific line of differentiation. The specificity of the inhibitor for haemopoietic stem cells suggests its potential value during chemotherapeutic procedures.
The proliferative status of haemopoietic stem cells measured as spleen colony-forming units or CFU-S (Till & McCulloch, 1961) can be regulated by endogenously derived inhibitory (Lord et al., 1976; Frindel & Guigon, 1977; Cork et al., 1981) and stimulatory (Frindel et al., 1976; Lord et al., 1977) factors. In 1972 Gidali & Lajtha, studying the kinetics of CFU-S behaviour following partial body irradiation came to the conclusion that the proliferation of CFU-S is regulated at a local level rather than by circulating factors. Retrospectively, the same conclusion was drawn from the work of Rencricca et al., (1970) who demonstrated different levels of CFU-S proliferation in bone marrow and spleen. Since the factors we have described are obtained from fresh, viable marrow -the inhibitor from normal adult marrow in which CFU-S are proliferatively quiescent; the stimulator from postirradiation marrow in which CFU-S are rapidly proliferating -we consider them probably to be at least a part of this local regulatory system. The inhibitor, described by Frindel & Guigon is obtained from other haemopoietic sources. It probably has a lower mol. wt and is interpreted by them to act humorally. The relationship between these two factors, if any, is, therefore, unclear and it should be pointed out that the data presented in this paper refer only to the inhibitor described by Lord et al., (1976) , and Cork et al., (1981 (1977) our material is at least relatively specific to the CFU-S population in that it has no effect on GM-CFC (granulocyte/macrophage colony-forming cells, in vitro) (Lord et al, 1976) . Similarly, Cork et al., (1982) found that the stimulator would not trigger proliferatively suppressed GM-CFC back into cycle.
The in vitro colony techniques have now been expanded for assaying other early committed progenitor cells, e.g., the erythroid burst-forming unit (BFU-E) and the mixed colony forming cell (CFC-mix) . This latter cell type is particularly important since its growth in vitro produces a wide range of recognisable blood-cell lines and consequently it is considered to be a very close temporal relative of the pluripotent CFU-S population, if not the same cell. Its absolute relationship to the CFU-S, however, is not known. It has a sedimentation velocity similar to that of the CFU-S (Johnson, 1980) and because of its multipotency, it is almost certainly more primitive than the BFU-E. On the other hand, its self renewal capacity is less than that of the CFU-S (Metcalf et al., 1979) (C57B19 x DBA2c) mice aged 8 to 10 weeks or liver from DBA2 foetuses aged approximately 14d were assayed for BFU-E, GM-CFC, CFC-mix and CFU-S. The proportion of cells in DNA-synthesis for each of these cell types was measured by the tritiated thymidine (3HTdR) suicide technique (Becker et al., 1965; Lord et al., 1974) . Inhibitor was obtained as a partially purified extract from normal bone marrow cells, NBME-IV (Lord et al., 1976) . Fresh murine bone marrow was suspended in saline at -107cells ml-I and maintained at room temperature for about 2 h before removing the cells by centrifugation. The cell free supernatant was then fractionated on Amicon Diaflo membranes and fraction IV, the 50-100 K dalton fraction, retained as the inhibitor. Stimulator (RBME-III) was similarly prepared as fraction III (the 30-50K dalton Amicon fraction) from marrow regenerating after a dose of 4.5 Gy y-rays (Lord et al., 1977) . The preparations were stored freeze dried until required.
BFU-E assay BFU-E colonies (bursts) were assayed by culturing 2 x 105 marrow cells from BDF1 mice in cx-medium supplemented with 0.9% methylcellulose, 15% foetal calf serum, FCS (Gibco), 5% horse serum (Flow), 10% w/v bovine serum albumin, BSA (Sigma), 2 u ml 1 erythropoietin (Connaught, Step III), 10-4M oc-thioglycerol, 10-7M sodium succinate and 10-3M L-glutamine. Irradiated (16Gy) bone marrow cells (106ml-1 of culture)
were added as a source of burst-promoting activity, BPA. The cultures were incubated at 370C in a fully humidified atmosphere of 5% CO2 in air and the erythroid bursts were scored after 7-8 days under an inverted microscope at 50 or 78 x magnification. They were colonies composed solely of erythroid cells, recognised by their size, haemoglobinisation and characteristic arrangement in tight clusters of multicentric bursts. (Till & McCulloch, 1961) . Recipient BDF1 mice (10 per group) were irradiated (13.5 Gy, 60Co y-rays at 0.85Gy h-1; Lord et al., 1984) Inhibitor Inhibitor (NBME-IV) was assayed in a similar manner to that for the stimulator. In this case, foetal liver cells were incubated for 2 h or 5 h. In either case, 3HTdR was added for the last 30min of incubation only. The dose of NBME-IV used lay in the range of 0 to 80 ,g ml-.
Results
Stimulator The potential of the extract from regenerating marrow to stimulate (or trigger) proliferation in various classes of early haemopoietic progenitor cells was assessed in two series of experiments. Using a common suspension of normal adult bone marrow cells, CFU-S, BFU-E and GM-CFC were first tested independently. The results are shown in Table I . The RBME-III caused a small, though not dose-related, reduction in the plating efficiency of GM-CFC but not in that of BFU-E or on the seeding efficiency of CFU-S: the number of colonies produced remained unchanged over a wide dose range of RBME-III. The proportion of CFU-S in DNA-synthesis (i.e., the proportion killed by 3HTdR) was increased from the non-significant level found in normal quiescent bone marrow CFU-S (6.5%) to -30% (P<«0.001) with a dose of 10 Ig ml-I or more. Although BFU-E and GM-CFC are rapidly proliferating in normal bone marrow their proliferation can be accelerated by appropriate stimuli. For example, in irradiated hypertransfused mice, the proportion of BFU-E in DNA-synthesis is increased from 30 to 63% (Iscove, 1977) . Similarly, the proliferative index of GM-CFC was increased from 35% in normal bone marrow to 80% in regenerating bone marrow (Iscove et al., 1970) . However, the proliferation of BFU-E and GM-CFC was not stimulated by RBME-III doses up to 30Optgml -. It should be noted that the marginal stimulation of GM-CFC with 20,ugmlml was very small compared to that for CFU-S (P=0.02 compared with P<0.001). However, there was no indication of a dose response (see below).
In the second series of experiments, foetal liver CFC-mix, BFU-E and GM-CFC were assayed in a single culture system. The results are shown in Table II . In this system, the plating efficiencies of all three cell types were unaffected by treatment with RBME-III. The 3HTdR suicide indices for BFU-E and GM-CFC were again unchanged (P= 0.06 to >0.9). CFC-mix, however, were triggered; the proportion killed by 3HTdR increasing from 25.7% to the plateau level of -60% with as little as 5 pg of the extract per ml (P<0.001). The small stimulation of GM-CFC at 20pgml-1 in the first series of experiments was not confirmed in these experiments where no change in proliferation was observed (P> 0.9). Neither was there any reduction in plating efficiency in these experiments.
Inhibitor The inhibitor (NBME-IV) was assayed against foetal liver CFC-mix, BFU-E and GM-CFC in the combined culture technique and, simultaneously, against CFU-S. The results are shown in Table III . The plating and seeding efficiencies of all cell types were largely unaffected as was the 3HTdR suicide index of all but the CFU-S. In this latter case, 20,jg NBME-IV per ml of cells reduced the proportion killed by 3HTdR from 31.5% to 10.1% after 5h incubation (P < 0.001). 40 ig ml-1 were required for inhibition when the incubation period was 2h only (36.4% to 9.7%) (P < 0.001). A marginal, but non-significant, reduction in kill was seen in GM-CFC after 5 h incubation at 40 jg ml -1 (P = 0.14).
In four of the fifteen sets of data for the in vitro colony forming cells there was an apparent stimulation of proliferation. These were, however, non-systematic changes and small by comparison with the highly significant inhibition of CFU-S proliferation.
Discussion
The haemopoietic stem cell complex has recently been described as a population with a well defined age structure, the most primitive cells having a high self-renewal and a low differentiation capacity while the more mature cells have a lower self-renewal and increased differentiation capacity (Schofield, 1978; Rosendaal et al., 1979) . This population of spleen colony-forming units (CFU-S) gives rise to the more restricted progenitor cells which separately lead to the production of red blood cells (BFU-E), granulocytes or macrophages (GM-CFC) etc. The development of an in vitro assay system for pluripotent cells indicated a CFC-mix which is pluripotent, has a degree of self renewal capacity and therefore, is at least very close to the CFU-S. RBME-III has been shown to stimulate normal CFU-S but not GM-CFC whose proliferative activity has been suppressed (Cork et al., 1982) . NBME-IV, on the other hand, inhibits regenerating CFU-S but not proliferating GM-CFC (Lord et al., 1976) . These two factors have, therefore, been taken as proliferation regulators which are active specifically against the CFU-S population. These observations have now been extended to include the other major derivative of the CFU-S, the erythroid progenitor cells. By including also the CFC-mix, the extent of the specificity could be better defined.
These experiments confirmed the specificity of both NBME-IV and RBME-III for the pluripotent cell forms. The stimulator, however, was active against both the CFU-S and the CFC-mix (Tables I  and II) while the inhibitor was active against the CFU-S only (Table III) . These observations are in accord with a separate series of experiments (Wright & Lord, in preparation) where it was found that the more primitive (12d) CFU-S are relatively more responsive to inhibitor while the maturer (7d) CFU-S are relatively more responsive to stimulator. Thus, the current observation that the stimulator's range of activity extends to the CFC-mix further suggests that this population arises at the more mature end of the CFU-S population. The range of activity of the inhibitor is probably restricted specifically to the purely CFU-S compartment. Once definable as a precursor committed to a specific line of development, however, a cell is no longer responsive to either of these stem cell regulating factors. the stem and committed cell populations and their relative sensitivities to inhibitor and stimulator. It is interesting to note that GM-CFC demonstrate a similar heterogeneity in response to simulation in that a cell's sensitivity to colony stimulating activity appears to be related to its clone size potential (Francis et al., 1981) . The ability to protect haemopoietic stem cells against the cytotoxic effects of S-phase specific agents such as is illustrated by the specificity of this inhibitor means that extra flexibility in the use of such drugs for chemotherapy should be possible. Preliminary experiments have illustrated its effectiveness in vivo (Lord and Wright, 1982) in a similar manner to that of the inhibitor described by Frindel and Guigon (1977) .
